文献速递血栓与止血

脓毒症期间止血管理策略

How we manage haemostasis during sepsis.
PubMed 文献 · Br J Haematol · 2019-03-03

脓毒症可激活凝血系统,严重时导致弥散性血管内凝血(DIC),初期以中小血管血栓形成为主并参与器官功能障碍,持续激活则消耗凝血因子导致全局凝血指标延长。血小板减少常为脓毒症首发特征,严重病例可伴低纤维蛋白原血症及纤溶通路过度激活,最终表现为出血表型。评分系统可利用常规实验室参数帮助识别DIC高危患者并辅助诊断,讨论涵盖从血栓状态到出血状态的止血医学与血制品支持。

要点

  • 脓毒症凝血激活初期以中小血管血栓为主,参与器官功能障碍。
  • 持续激活消耗凝血因子,导致全局凝血指标延长及出血表型。
  • 评分系统可利用常规实验室参数辅助识别DIC高危患者并确诊。

核心结论

  • 脓毒症相关凝血激活从血栓状态进展至出血状态,评分系统可利用常规实验室参数辅助识别DIC高危患者并帮助确诊DIC。

研究设计与样本

  • 原文为综述,检索范围原文未报告。

主要发现

  • 脓毒症初期血栓主要累及中小血管并参与器官功能障碍,持续激活导致凝血因子消耗及全局凝血参数延长。
  • 血小板减少常为脓毒症初始特征,之后可出现全局凝血试验延长,严重病例伴低纤维蛋白原血症及纤溶通路过度激活,最终表现为出血表型。

关键数值与推荐

  • 原文未报告具体评分系统的阈值或数值。

临床怎么用

  • 讨论涵盖脓毒症触发背景下从血栓状态到出血状态的止血医学与血制品支持。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sepsis may be associated with activation of the coagulation system and, in its most severe form, may result in disseminated intravascular coagulation (DIC). Initially, there is thrombosis primarily affecting small and medium sized vessels and contributing to organ dysfunction, but continued activation results in consumption of coagulation factors. This results in prolongation of global coagulation parameters. Often thrombocytopenia is the initial feature in sepsis, which may be followed by prolongation of global coagulation assays, and in severe cases, associated with hypofibrinogenaemia, with overactivation of the fibrinolytic path. The end result is a bleeding phenotype. Scoring systems can be used to help identify patients at risk of DIC and aid in confirming a diagnosis of DIC utilising routine laboratory parameters. Discussion includes medical and blood product support of haemostasis, from thrombotic to bleeding states, in relation to sepsis trigger.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Scully M, Levi M. How we manage haemostasis during sepsis. Br J Haematol. 2019. PMID: 30828800. doi:10.1111/bjh.15821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。